Mini Review
Published on 01 Apr 2021
Low-Dose IL-2 Therapy in Autoimmune and Rheumatic Diseases
in Immunological Tolerance and Regulation
Frontiers in Immunology
doi 10.3389/fimmu.2021.648408
- 40,557 views
- 152 citations
24 articles related to "Low Dose Il 2"
Articles
Original Research
Published on 14 Mar 2022
Modification of Intestinal Microbiota Dysbiosis by Low-Dose Interleukin-2 in Dermatomyositis: A Post Hoc Analysis From a Clinical Trial Study
in Microbiome in Health and Disease
Frontiers in Cellular and Infection Microbiology
doi 10.3389/fcimb.2022.757099
- 5,769 views
- 23 citations
Original Research
Published on 06 Feb 2025
The absolute number of circulating Treg cells is reduced in difficult-to-treat RA patients and is ameliorated by low-dose IL-2
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2025.1522893
- 4,271 views
- 2 citations
Clinical Trial
Published on 22 Apr 2024
The efficacy and safety of short-term and low-dose IL-2 combined with tocilizumab to treat rheumatoid arthritis
in Immunological Tolerance and Regulation
Frontiers in Immunology
doi 10.3389/fimmu.2024.1359041
- 6,158 views
- 11 citations
Original Research
Published on 29 Nov 2022
Low-dose IL-2 improved clinical symptoms by restoring reduced regulatory T cells in patients with refractory rheumatoid arthritis: A randomized controlled trial
in Autoimmune and Autoinflammatory Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2022.947341
- 8,185 views
- 23 citations
Original Research
Published on 24 Feb 2021
HLA-Restriction of Human Treg Cells Is Not Required for Therapeutic Efficacy of Low-Dose IL-2 in Humanized Mice
in T Cell Biology
Frontiers in Immunology
doi 10.3389/fimmu.2021.630204
- 7,127 views
- 15 citations
Review
Published on 12 Sep 2023
Pathogenesis and novel therapeutics of regulatory T cell subsets and interleukin-2 therapy in systemic lupus erythematosus
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2023.1230264
- 13,070 views
- 26 citations
Review
Published on 02 May 2023
The potential of regulatory T cell-based therapies for alopecia areata
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2023.1111547
- 12,712 views
- 19 citations
Review
Published on 08 Mar 2023
The effect of combining PD-1 agonist and low-dose Interleukin-2 on treating systemic lupus erythematosus
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2023.1111005
- 9,872 views
- 11 citations
Original Research
Published on 09 Dec 2021
Impact of NK Cell Activating Receptor Gene Variants on Receptor Expression and Outcome of Immunotherapy in Acute Myeloid Leukemia
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2021.796072
- 5,058 views
- 10 citations
Mini Review
Published on 25 Jan 2019
Targeting Tregs in Juvenile Idiopathic Arthritis and Juvenile Dermatomyositis—Insights From Other Diseases
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2019.00046
- 8,951 views
- 15 citations
Review
Published on 16 Jul 2021
Potential for Antigen-Specific Tolerizing Immunotherapy in Systematic Lupus Erythematosus
in Immunological Tolerance and Regulation
Frontiers in Immunology
doi 10.3389/fimmu.2021.654701
- 10,167 views
- 22 citations
Review
Published on 23 Apr 2025
A glimpse into the application of the immunomodulatory effect of IL-2 in systemic lupus erythematosus
in Rheumatology
Frontiers in Medicine
doi 10.3389/fmed.2025.1552473
- 3,505 views
Original Research
Published on 23 Dec 2022
Membrane-bound IL-2 improves the expansion, survival, and phenotype of CAR Tregs and confers resistance to calcineurin inhibitors
in Alloimmunity and Transplantation
Frontiers in Immunology
doi 10.3389/fimmu.2022.1005582
- 9,984 views
- 24 citations
Original Research
Published on 18 Jun 2018
Anti-Leukemic Properties of Histamine in Monocytic Leukemia: The Role of NOX2
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2018.00218
- 6,059 views
- 27 citations
Brief Research Report
Published on 18 Dec 2019
Superior Treg-Expanding Properties of a Novel Dual-Acting Cytokine Fusion Protein
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2019.01490
- 6,590 views
- 15 citations